Intellia Therapeutics} stock has undergone multiple analysts rating changes in the recent past. Intellia Therapeutics Upgraded by Zacks Investment Research on 10/12/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Sell.
View More Intellia Therapeutics (NTLA) Upgraded by Zacks Investment Research to Hold
Quarterly, annual earnings. See the latest EPS estimates vs Actual and surprise it caused. Stock Market Daily has their analysis…
View More thoughts on these estimates, before EPS results? NASDAQ:CSWI, NASDAQ:FLXN, NASDAQ:NTLA, NYSE:USM
Earnings results for Intellia Therapeutics , Analyst Opinion on Intellia Therapeutics , Earnings and Valuation of (NASDAQ:NTLA), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,
View More Nothing seems to bother Intellia Therapeutics (NASDAQ:NTLA)
Earnings results for Intellia Therapeutics , Analyst Opinion on Intellia Therapeutics , Earnings and Valuation of (NASDAQ:NTLA), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,
View More Earnings and Growth Analysis : Intellia Therapeutics (NASDAQ:NTLA)
Quarterly, annual earnings. See the latest EPS estimates vs Actual and surprise it caused. Stock Market Daily has their analysis…
View More Earnings Scorecard & Analyst Reports for NYSE:VIST, NASDAQ:NTLA, NYSE:BPMP, NASDAQ:SRTS
Earnings results for Intellia Therapeutics , Analyst Opinion on Intellia Therapeutics , Earnings and Valuation of (NASDAQ:NTLA), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,
View More Is it time to Buy before this week’s earning report Intellia Therapeutics (NASDAQ:NTLA)
Quarterly, annual earnings. See the latest EPS estimates vs Actual and surprise it caused. Stock Market Daily has their analysis…
View More numbers crunched for you before earnings results NASDAQ:NTRA, NYSE:HFC, NASDAQ:NTLA, NYSE:QUOT
Quarterly, annual earnings. See the latest EPS estimates vs Actual and surprise it caused. Stock Market Daily has their analysis…
View More Must-See Earnings Estimates for: NYSE:DIN, NYSE:VALE, NYSE:COR, NASDAQ:NTLA
Earnings results for Intellia Therapeutics , Analyst Opinion on Intellia Therapeutics , Earnings and Valuation of (NASDAQ:NTLA), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,
View More Factors Likely to Have Influenced Earnings Results Intellia Therapeutics (NASDAQ:NTLA)
